Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
62 /100
HIGH RISK
Score updated Aug 28, 2026

OGEN — Oragenics, Inc. Dilution Risk Tracker

Track OGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OGEN — Get alerts when the score changes →

As of August 28, 2026, Oragenics, Inc. (OGEN) has a DilutionWatch DilutionScore of 62/100, rated HIGH dilution risk. Oragenics, Inc. has a market capitalization of $2.73M, 4.51M shares outstanding, 10 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 47%
🔄 Reverse Split model est. 65%
• 50-day avg $0.62 below $1 exchange minimum
• 10 months cash with weak price
🔁 Convertible Conversion model 40%
• Significant convertible debt: 28% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track OGEN — Get forecast alerts →

Market Data

Market Cap$2.73M
Shares Outstanding4.51M
Float4.41M
Cash$7.86M
Debt$56.1K
Short InterestN/A

Institutional Holdings

10 institutional holders · 190.1K shares
#1 Geode Capital Management, LLC 65.1K shares
#2 Pathstone Holdings, LLC 55.0K shares
#3 Two Sigma Securities, LLC 20.3K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest781.1K
Days to Cover31.3
% of Float17.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2015-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual OGEN Dilution Snapshot

Oragenics, Inc. (OGEN) has a DilutionScore of 62/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track OGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OGEN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OGEN
OGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.